Darmiyan Inc. (www.darmiyan.com) is a Bay area based healthtech company innovating at the cross-section of neuroimaging, data, ML/ AI, & neurodegenerative diseases. Founded in 2016 by a team of highly trained neuroscientists, clinicians, and AI experts, Darmiyan’s vision is to leverage technology to make a global impact on the lives of mild cognitive impairment, Alzheimer’s disease, and dementia patients. Darmiyan’s mission is to help postpone/ prevent dementia through:
– Early detection
– Monitoring patient-specific response to interventions
– Using data to advance drug development for Alzheimer’s disease
Darmiyan is backed by a number of highly credible investors including Y Combinator, IT-Farm, Eisai, & SOMPO.